TW200716096A - Combination drug - Google Patents
Combination drugInfo
- Publication number
- TW200716096A TW200716096A TW095114109A TW95114109A TW200716096A TW 200716096 A TW200716096 A TW 200716096A TW 095114109 A TW095114109 A TW 095114109A TW 95114109 A TW95114109 A TW 95114109A TW 200716096 A TW200716096 A TW 200716096A
- Authority
- TW
- Taiwan
- Prior art keywords
- combination drug
- combination
- supeirior
- dpp
- prophylactic
- Prior art date
Links
- 229940000425 combination drug Drugs 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 abstract 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 abstract 1
- 229940121931 Gluconeogenesis inhibitor Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- QJRYYOWARFCJQZ-UHFFFAOYSA-N pyrrolidine-1-carbonitrile Chemical class N#CN1CCCC1 QJRYYOWARFCJQZ-UHFFFAOYSA-N 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005124495A JP2008115080A (ja) | 2005-04-22 | 2005-04-22 | 併用医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200716096A true TW200716096A (en) | 2007-05-01 |
Family
ID=36636547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095114109A TW200716096A (en) | 2005-04-22 | 2006-04-20 | Combination drug |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2008115080A (zh) |
| TW (1) | TW200716096A (zh) |
| WO (1) | WO2006115289A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5072848B2 (ja) | 2005-09-20 | 2012-11-14 | ノバルティス アーゲー | 低血糖イベントを低減するためのｄｐｐ−ｉｖ阻害剤の使用 |
| WO2008113000A1 (en) * | 2007-03-15 | 2008-09-18 | Nectid, Inc. | Anti-diabetic combinations comprising a slow release biguanide composition and an immediate release dipeptidyl peptidase iv inhibitor composition |
| US8551524B2 (en) | 2008-03-14 | 2013-10-08 | Iycus, Llc | Anti-diabetic combinations |
| WO2010074271A1 (ja) * | 2008-12-26 | 2010-07-01 | 武田薬品工業株式会社 | 糖尿病治療剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1741446T3 (da) * | 2000-01-21 | 2008-06-02 | Novartis Pharma Ag | Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler |
| US6395767B2 (en) * | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| GB0014969D0 (en) * | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| TWI243162B (en) * | 2000-11-10 | 2005-11-11 | Taisho Pharmaceutical Co Ltd | Cyanopyrrolidine derivatives |
| WO2003057144A2 (en) * | 2001-12-26 | 2003-07-17 | Guilford Pharmaceuticals | Change inhibitors of dipeptidyl peptidase iv |
| US7935723B2 (en) * | 2004-06-04 | 2011-05-03 | Novartis Pharma Ag | Use of organic compounds |
-
2005
- 2005-04-22 JP JP2005124495A patent/JP2008115080A/ja active Pending
-
2006
- 2006-04-20 TW TW095114109A patent/TW200716096A/zh unknown
- 2006-04-21 WO PCT/JP2006/308926 patent/WO2006115289A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006115289A1 (en) | 2006-11-02 |
| JP2008115080A (ja) | 2008-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249715B (en) | N-butyl-deoxynojirimycin for use as a drug for the treatment of Pompe disease in combination with an enzyme replacement therapy agent | |
| WO2011012746A3 (es) | Compuestos inhibidores de apaf-1 | |
| NZ619520A (en) | Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics | |
| GEP20135838B (en) | Dipeptidyl peptidase inhibitors usage at diabetes treatment | |
| EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
| UA100111C2 (ru) | Лечение диабета типа 2 комбинацией ингибитора dpiv и метформина или тиазолидиндиона | |
| PL2247602T3 (pl) | Pochodne O-glukuronido-adamantylowe jako inhibitory dipeptydylopeptydazy IV do leczenia cukrzycy | |
| EP2036574A4 (en) | MEDICAL AGENT FOR THE TREATMENT OF FAT, DIABETES AND DISEASES IN CONNECTION WITH IMPROVED GLUCOSE TOLERANCE | |
| CR9220A (es) | Terapia combinatoria para el tratamiento de la diabetes y de condiciones relacionadas con la misma o para el tratamiento de condiciones mejoradas aumentando un nivel de glp-1 en sangre. | |
| IL189212A0 (en) | Therapeutic agent for diabetes | |
| TN2011000176A1 (en) | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug | |
| MX2013008484A (es) | Prevencion de hidroglucemia en pacientes con diabetes mellitus tipo 2. | |
| PH12012500382A1 (en) | Heterocyclic compounds for the inhibition of pask | |
| UY33025A (es) | Composicion farmaceutica que comprende un agonista de glp-1 metionina | |
| PL2275108T3 (pl) | Preparat farmaceutyczny zawierający inhibitor dpp-iv i inny terapeutyczny środek na cukrzycę w postaci stosowanej równocześnie lub w postaci połączonej | |
| MY159865A (en) | Aqueous insulin preparations containing methionine | |
| WO2006053043A3 (en) | Methods of treating diabetes mellitus | |
| IL192369A0 (en) | Therapeutic agent for diabetes | |
| WO2007128973A3 (en) | Interleukin 1-receptor antagonist composition to treat restenosis | |
| EP2015800A4 (en) | MEDICAL INJECTOR WITH FRONT LOADING AND CORRESPONDING SYRINGES | |
| WO2007106884A3 (en) | Methods of treating muscular wasting diseases using nf-kb activation inhibitors | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| BRPI0908168A2 (pt) | composto, medicamento, inibidor de dipeptidil peptidase-iv, agente terapêutico para diabetes, e, método de tratamento de diabetes | |
| SG160415A1 (en) | Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative | |
| TW200716096A (en) | Combination drug |